Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05994820 |
Recruitment Status :
Completed
First Posted : August 16, 2023
Last Update Posted : March 1, 2024
|
Sponsor:
Johns Hopkins Bloomberg School of Public Health
Information provided by (Responsible Party):
Johns Hopkins Bloomberg School of Public Health
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date ICMJE | August 9, 2023 | ||||
First Posted Date ICMJE | August 16, 2023 | ||||
Last Update Posted Date | March 1, 2024 | ||||
Actual Study Start Date ICMJE | September 26, 2023 | ||||
Actual Primary Completion Date | February 10, 2024 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
|
||||
Original Primary Outcome Measures ICMJE | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures ICMJE |
Parental Awareness of Vaccine Services [ Time Frame: 4 months ] Awareness will be assessed through 2 knowledge based questions on a questionnaire administered after the intervention. Responses will scored on a three-point scale: 0 = not aware; 1 = aware but does not know the date; and 2= aware and knows the date. Higher scores correspond to greater awareness.
|
||||
Original Secondary Outcome Measures ICMJE | Same as current | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title ICMJE | Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India | ||||
Official Title ICMJE | Implementing and Evaluating a Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India | ||||
Brief Summary | The goal of this clinical trial is to learn compare the efficacy Chatbot messaging directed to parents of infants and children living in unstable urban housing (UUH) in Varansi, India. The main questions it aims to answer are: 1) Can a Chatbot intervention be used to improve attitudes towards childhood vaccines? 2) Does an intervention in which vaccination is presented in the larger context of well-being improve attitudes towards vaccination? | ||||
Detailed Description | Only 2/3 of Indian infants and children are fully immunized. In communities facing unstable urban housing (UUH) vaccination rates are even lower. COVID-19 introduced new challenges for community health workers in these areas, and many do not have the capacity to promote vaccination. At the same time, the pandemic also prompted more parents and caregivers to engage with smartphones to manage the child's health. The investigators believe that a WhatsApp-based Chatbot intervention may be an effective way to promote routine childhood vaccination among caregivers without creating additional burdens on community health workers. To test this, the investigators are developing the Happy Baby Programme. This programme will be disseminated as a Chatbot through WhatsApp to parents of infants and young children living in Varanasi, in the Indian state of Uttar Pradesh. In addition to testing the overall efficacy of a Chatbot messaging platform, the investigators will compare two different Chatbot messaging designs, one featuring vaccine-only messaging and a second that positions vaccines as part of a broader set of well-being practices. | ||||
Study Type ICMJE | Interventional | ||||
Study Phase ICMJE | Not Applicable | ||||
Study Design ICMJE | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Masking Description: All parties are aware of assignment Primary Purpose: Other
|
||||
Condition ICMJE | Vaccine Hesitancy | ||||
Intervention ICMJE |
|
||||
Study Arms ICMJE |
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Completed | ||||
Actual Enrollment ICMJE |
2058 | ||||
Original Estimated Enrollment ICMJE |
1950 | ||||
Actual Study Completion Date ICMJE | February 10, 2024 | ||||
Actual Primary Completion Date | February 10, 2024 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender ICMJE |
|
||||
Ages ICMJE | 18 Years and older (Adult, Older Adult) | ||||
Accepts Healthy Volunteers ICMJE | Yes | ||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries ICMJE | India | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT05994820 | ||||
Other Study ID Numbers ICMJE | IRB00023512 IRB00023512 ( Other Identifier: JHSPH IRB ) |
||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement ICMJE |
|
||||
Current Responsible Party | Johns Hopkins Bloomberg School of Public Health | ||||
Original Responsible Party | Same as current | ||||
Current Study Sponsor ICMJE | Johns Hopkins Bloomberg School of Public Health | ||||
Original Study Sponsor ICMJE | Same as current | ||||
Collaborators ICMJE | Not Provided | ||||
Investigators ICMJE |
|
||||
PRS Account | Johns Hopkins Bloomberg School of Public Health | ||||
Verification Date | February 2024 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |